BEES Stock UPDATES Bnh Inc. (BEES) 0.0300 09/11/2014 05:54:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bnh Inc. (BEES) 0.0300 $BEES

BeesFree Announces the Appointment of Steven F. Elliott as its new President and Chief Executive Officer
PR Newswire - Tue Feb 18, 7:00AM CST
BeesFree, Inc. (BEES) today announced the appointment of Steven F. Elliott as its next President and Chief Executive Officer effective immediately.

BeesFree Receives Large Initial Sales Order of BeesVita Plus(TM) from Major Distributor of Bee Products in Argentina
PR Newswire - Mon Sep 16, 8:00AM CDT
BeesFree, Inc. (OTC QB:BEES), the worldwide distributor of BeesVita Plus(TM), announced that it has received an order of approximately $300,000USD from a major distributor of products to many of the largest beekeepers in Argentina. The order was generated as a result of the recently announced collaboration with Oleogram SA, an Argentine company recognized as an expert in new product and technology development in the agricultural sector.

BeesFree Signs Second Manufacturing Agreement to Supply United States Market with BeesVita Plus
PR Newswire - Thu Aug 22, 9:19AM CDT
BeesFree, Inc. (OTC QB: BEES) continues to position itself as the world leader in creating, manufacturing and marketing an effective treatment for the treatment of Colony Collapse Disorder (CCD) by announcing a manufacturing agreement with Form-A-Feed Inc. to supply the entire United States market with BeesVita Plus(TM). With an operating history of over 40 years, Minnesota-based Form-A-Feed (http://www.formafeed.com) employs over 100 people through 9 divisions with a focus on introducing new ideas, concepts and products to the livestock industry.

BeesFree Signs New Sales and Cooperation Agreement for the Distribution and Marketing of BeesVita(TM) Plus in Argentina
PR Newswire - Wed Jul 31, 11:17AM CDT
BeesFree, Inc. (OTC QB: BEES), the worldwide distributor of BeesVita Plus(TM), an innovative composite food supplement for honeybees that strengthens the bee's immune system and prevents the effects of Colony Collapse Disorder(CCD), announced today that a master cooperation and sales agreement has been signed by it's wholly-owned subsidiary in Argentina. The agreement was signed with Oleogram SA, an Argentine company recognized as an expert for new product and technology development in the agricultural sector. Oleogram signed this agreement with BeesFree's subsidiary for the purpose of using BeesVita(TM) Plus to maintain honey bee health and to sustain the growth of the honey bee population and productivity in Argentina.

BeesFree Executive Team Meets with Top Officials in the State of Iowa as BeesVita Plus Product Launch Gains Momentum and Receives Attention from Accredited Investors in America's Heartland
PR Newswire - Fri Jul 26, 12:41PM CDT
BeesFree, Inc. (OTC QB: BEES), the worldwide distributor of BeesVita Plus(TM), an innovative composite food supplement for honeybees that strengthens the bee's immune system and prevents the effects of Colony Collapse Disorder (CCD), announced today that Dr. Andrea Festuccia, Chairman of BeesFree, Inc. and other members of BeesFree's executive team met with the Iowa Economic Development Authority, Iowa State University and private accredited investors in the state of Iowa. The Iowa Economic Development Authority's mission is to strengthen economic and community vitality within Iowa to make Iowa the choice for people and businesses. As a result of the enthusiasm from local officials in Iowa coupled with the response from accredited investors in Iowa, BeesFree is considering relocating the company's U.S. headquarters to Ames Iowa. BeesFree currently maintains offices in West Palm Beach, Buenos Aires and Rome.

BeesFree Signs Manufacturing Agreement in Argentina to Meet Substantial BeesFree Product Demand for All of South America
PR Newswire - Wed Jul 24, 1:39PM CDT
BeesFree, Inc. (OTC QB: BEES), the worldwide distributor and creator of BeesVita Plus(TM), an innovative composite food supplement for honeybees that strengthens the bee's immune system and prevents the effects of Colony Collapse Disorder (CCD), announced a new manufacturing agreement with Ledyi Laboratories of Argentina.

BeesFree Sponsors the 2013 North American Beekeeping Conference & Tradeshow
PR Newswire - Wed Jan 09, 7:39AM CST
BeesFree, Inc. (OTC QB: BEES) announced today that it is a Bronze Sponsor for the 2013 North American Beekeeping (NAB) Conference & Tradeshow. The conference is being held January 8th - 12thin Hershey, Pennsylvania at the Hershey® Lodge. BeesFree, Inc. is the worldwide distributor of both BeesVita Plus(TM), an innovative composite nutritional food supplement for honey bees that promotes healthier honey bees and works to prevent the effects of Colony Collapse Disorder (CCD), and the Beespenser(TM), an automated external honey bee feeding system. Colony Collapse Disorder (CCD) is a phenomenon in which worker bees from a beehive abruptly disappear.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading